Filter Results:
(2,460)
Show Results For
- All HBS Web
(2,460)
- People (6)
- News (578)
- Research (1,758)
- Events (11)
- Multimedia (14)
- Faculty Publications (1,389)
Show Results For
- All HBS Web
(2,460)
- People (6)
- News (578)
- Research (1,758)
- Events (11)
- Multimedia (14)
- Faculty Publications (1,389)
- Forthcoming
- Article
On the Limits of Anonymization for Promoting Diversity in Organizations
By: Linda W. Chang and Edward H. Chang
Anonymization of job applicant resumes is a recommended strategy to increase diversity in organizations, but large-scale tests have shown mixed results. We consider decision-makers’ social dominance orientation (SDO), a measure of anti-egalitarianism/endorsement of... View Details
Chang, Linda W., and Edward H. Chang. "On the Limits of Anonymization for Promoting Diversity in Organizations." Personality and Social Psychology Bulletin (forthcoming). (Pre-published online January 3, 2025.)
- Article
Populism and the Return of the 'Paranoid Style': Some Evidence and a Simple Model of Demand for Incompetence as Insurance against Elite Betrayal
By: Rafael Di Tella and Julio J. Rotemberg
We present a simple model of populism as the rejection of “disloyal” leaders. We show that adding the assumption that people are worse off when they experience low income as a result of leader betrayal (than when it is the result of bad luck) to a simple voter choice... View Details
Di Tella, Rafael, and Julio J. Rotemberg. "Populism and the Return of the 'Paranoid Style': Some Evidence and a Simple Model of Demand for Incompetence as Insurance against Elite Betrayal." Journal of Comparative Economics 46, no. 4 (December 2018): 988–1005.
- 11 Jun 2021
- News
The Power of Resilience
home as well, since they had come to to help with the baby, and now were staying to help with my treatment. About six months into my treatment journey, I did return back to the startup that I was working with and continued to work with... View Details
- August 2018
- Article
The Impact of the Entry of Biosimilars: Evidence from Europe
By: Fiona M. Scott Morton, Ariel Dora Stern and Scott Stern
Biologics represent a substantial and growing share of the U.S. drug market. Traditional “small molecule” generics quickly erode the price and share of the branded product upon entry; however, only a few biosimilars have been approved in the U.S. since 2015, thereby... View Details
Keywords: Health Care; Biosimilars; Biologics; Pharmaceutical Competition; Healthcare Spending; Innovation; Health Care and Treatment; Spending; Market Entry and Exit; Competition; Innovation and Invention; Pharmaceutical Industry; United States; Europe
Scott Morton, Fiona M., Ariel Dora Stern, and Scott Stern. "The Impact of the Entry of Biosimilars: Evidence from Europe." Review of Industrial Organization 53, no. 1 (August 2018): 173–210.
- January 2008 (Revised August 2012)
- Case
Retail Sales of Health Insurance: Blue Cross Blue Shield of Florida
By: Regina E. Herzlinger and Grady Clouse
The BCBS of Florida is contemplating whether to enter the consumer-driven health care market and if so, whether to target such groups—and individuals—and in which of its geographic markets, and how. View Details
- September 2012
- Supplement
Intraoperative Radiotherapy for Breast Cancer (B)
By: Willy Shih
The intraoperative radiotherapy (IORT) business at Carl Zeiss Meditec had struggled with growth since the time of the (A) case. Though the unit had grown revenues in excess of 50% and had exceeded its EBIT target, it faced several key strategic choices. Should it... View Details
Keywords: Radiotherapy; Breast Cancer; Brachytherapy; Therapeutic Radiation; Oncology; Oncology Treatment Systems; Elekta AB; Varian Medical Systems; Xoft; Electronic Brachytherapy; Intraoperative Radiotherapy; Disruptive Innovation; Health Care and Treatment; Entrepreneurship; Technological Innovation; Growth and Development Strategy; Health Industry; Germany
Shih, Willy. "Intraoperative Radiotherapy for Breast Cancer (B)." Harvard Business School Supplement 613-040, September 2012.
- 01 Jun 2013
- News
School of Hard Knocks
1988) is a New York Times best-selling author, speaker, and chief engagement officer of Illinois-based Kevin Sheridan LLC. Visit http://kevinsheridanllc.com/books. Photo courtesy of Kevin Sheridan Studies... View Details
- March 2003
- Article
Technological Development and Medical Productivity: The Diffusion of Angioplasty in New York State
By: David M. Cutler and Robert S. Huckman
A puzzling feature of many medical innovations is that they simultaneously appear to reduce unit costs and increase total costs. We consider this phenomenon by examining the diffusion of percutaneous transluminal coronary angioplasty (PTCA)—a treatment for coronary... View Details
Keywords: Innovation and Invention; Cost; Health Care and Treatment; Health Disorders; Performance Improvement; Product; New York (state, US)
Cutler, David M., and Robert S. Huckman. "Technological Development and Medical Productivity: The Diffusion of Angioplasty in New York State." Journal of Health Economics 22, no. 2 (March 2003): 187–217.
- 01 Mar 2008
- News
A History of Women at HBS
treatment of human problems in any employment situation.” HBS professor Fritz J. Roethlisberger, renowned for his work in the field of human relations (see December 2007... View Details
- 12 May 2015
- News
A Flash of Insight
When American Airlines Flight 11 struck the North Tower of the World Trade Center on the bright, sunny morning of September 11, 2001, it set off a chain of dark events that... View Details
- 22 Aug 2005
- Research & Ideas
The Hard Work of Failure Analysis
It hardly needs to be said that organizations cannot learn from failures if people do not discuss and analyze them. Yet this remains an important insight. The learning that is potentially available may not be realized unless thoughtful analysis and discussion View Details
Keywords: by Amy Edmondson & Mark D. Cannon
- 01 Jun 2012
- News
The Power of Philanthropy
When their son Joey died of cystic fibrosis in 1986 at age 12, Kathy and Joe O’Donnell (MBA 1971) vowed to fight the disease. O’Donnell, at the time the president of the Boston Concessions Group, joined with... View Details
- 2023
- Working Paper
State Employment as a Strategy of Autocratic Control in China
By: Jaya Y. Wen
This paper presents evidence that autocrats use state-owned firms to strategically pacify social unrest via employment provision, a role that may contribute to their favorable treatment and persistence across settings. I use variation in a regional conflict between... View Details
Wen, Jaya Y. "State Employment as a Strategy of Autocratic Control in China." Working Paper, January 2023.
- February 2025
- Article
Sale of Private Equity–Owned Physician Practices and Physician Turnover
By: Victoria Berquist, Lev Klarnet and Leemore Dafny
Private equity (PE) ownership of physician practices is increasing, with owners targeting sales, or exits, in 3 to 7 years. Little is known about the association of exit with physician retention and subsequent employment. Using panel data over the period 2014-2020, we... View Details
Berquist, Victoria, Lev Klarnet, and Leemore Dafny. "Sale of Private Equity–Owned Physician Practices and Physician Turnover." JAMA Health Forum 6, no. 2 (February 2025).
- 15 Mar 2021
- Working Paper Summaries
The Health Costs of Cost-Sharing
- 16 Jul 2019
- News
The Making of a Movement
making decisions that could advance treatment options for patients with rare cancers. Neither of the Linns worked in science or medicine. A few years earlier, rare cancers had not even been on their radar.... View Details
- January 2009
- Case
When Supply is of Public Interest: Roche & Tamiflu
The case focuses on the challenges of Roche maintaining a supply network for a global influenza pandemic response initiative based on its antiviral drug Tamiflu. The Roche group is a 40 billion CHF company consisting of a pharmaceutical division and a diagnostic... View Details
Keywords: Global Strategy; Health Pandemics; Distribution; Logistics; Production; Supply Chain Management; Performance Capacity; Pharmaceutical Industry
Watson, Noel H., Laura Rock Kopczak, and Prashant Yadav. "When Supply is of Public Interest: Roche & Tamiflu." Harvard Business School Case 609-061, January 2009.
- 17 Nov 2003
- Research & Ideas
The Business of Babies
wish not to see, she said. "We have a business that doesn't feel like a business," said Spar. "Nobody wants to acknowledge the extent of commercialization." Yet Americans alone spent $2.7 billion on fertility View Details
- 2021
- Working Paper
MLS as a Sports Product—The Prominence of the World's Game in the U.S.
By: Stephen A. Greyser and Kenneth Cortsen
The purpose of this Working Paper is to analyze how soccer at the professional level in the U.S., with Major League Soccer as a focal point, has developed over the span of a quarter of a century. It is worthwhile to examine the growth of Major League Soccer (MLS) from... View Details
Keywords: Soccer; Major League Soccer; Sports; Growth and Development; Organizational Structure; Business Model; Sports Industry; United States
Greyser, Stephen A., and Kenneth Cortsen. "MLS as a Sports Product—The Prominence of the World's Game in the U.S." Harvard Business School Working Paper, No. 21-111, March 2021. (Revised April 2021.)
- 14 Mar 2019
- News
The Merchant of Osaka
by Jen McFarland Flint; photographed by Takashi Yasui Sato-san’s hospital bed is wedged diagonally across his living room, relics of regular life pushed to the perimeter. For four years the retired accountant traveled back and forth to a... View Details
Keywords: Health, Social Assistance